Search Results - "Markulev, C."

The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo by McHugh, M.J., McGorry, P.D., Yuen, H.P., Hickie, I.B., Thompson, A., de Haan, L., Mossaheb, N., Smesny, S., Lin, A., Markulev, C., Schloegelhofer, M., Wood, S.J., Nieman, D., Hartmann, J.A., Nordentoft, M., Schäfer, M., Amminger, G.P., Yung, A, Nelson, B.

“…Individuals are considered Ultra-High-Risk (UHR) for psychosis if they meet a set of standardised criteria including presumed genetic vulnerability (Trait), or…”
Get full text

Dynamic prediction of transition to psychosis using joint modelling by Yuen, H.P., Mackinnon, A., Hartmann, J., Amminger, G.P., Markulev, C., Lavoie, S., Schäfer, M.R., Polari, A., Mossaheb, N., Schlögelhofer, M., Smesny, S., Hickie, I.B., Berger, G., Chen, E.Y.H., de Haan, L., Nieman, D.H., Nordentoft, M., Riecher-Rössler, A., Verma, S., Thompson, A., Yung, A.R., McGorry, P.D., Nelson, B.

“…Considerable research has been conducted seeking risk factors and constructing prediction models for transition to psychosis in individuals at ultra-high risk…”
Get full text

Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes by Youn, S., Phillips, L.J., Amminger, G.P., Berger, G., Chen, E.Y.H., de Haan, L., Hartmann, J.A., Hickie, I.B., Lavoie, S., Markulev, C., McGorry, P.D., Mossaheb, N., Nieman, D.H., Nordentoft, M., Riecher-Rössler, A., Schäfer, M.R., Schlögelhofer, M., Smesny, S., Thompson, A., Verma, S., Yuen, H.P., Yung, A.R., Nelson, B.

“…There has been limited research into the predictive value of basic symptoms and their relationship with other psychopathology in patients identified using the…”
Get full text

Do schizotypal or borderline personality disorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in patients at high clinical risk? by Hadar, H., Zhang, H., Phillips, L.J., Amminger, G.P., Berger, G.E., Chen, E.Y.H., de Haan, L., Hartmann, J.A., Hickie, I.B., Lavoie, S., Markulev, C., McGorry, P.D., Mossaheb, N., Nieman, D.H., Nordentoft, M., Riecher-Rössler, A., Schäfer, M.R., Schlögelhofer, M., Smesny, S., Thompson, A., Verma, S., Yuen, H.P., Yung, A.R., Nelson, B.

Get full text

Pituitary volume and early treatment response in drug-naïve first-episode psychosis patients by Garner, B, Berger, G.E, Nicolo, J.P, Mackinnon, A, Wood, S.J, Pariante, C.M, Dazzan, P, Proffitt, T.M, Markulev, C, Kerr, M, McConchie, M, Phillips, L.J, Pantelis, C, McGorry, P.D

“…Abstract Background An early response to antipsychotic treatment in patients with psychosis has been associated with a better course and outcome. However,…”
Get full text

NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders—medium-term follow-up and clinical course by Nelson, B., Amminger, G. P., Yuen, H. P., Markulev, C., Lavoie, S., Schäfer, M. R., Hartmann, J. A., Mossaheb, N., Schlögelhofer, M., Smesny, S., Hickie, I. B., Berger, G., Chen, E. Y. H., de Haan, L., Nieman, D. H., Nordentoft, M., Riecher-Rössler, A., Verma, S., Thompson, A., Yung, A. R., McGorry, P. D.

“…This study reports a medium-term follow-up of a randomised, double-blind, placebo-controlled trial of omega-3 polyunsaturated fatty acids (PUFA) in ultra-high…”
Get full text

Distress related to attenuated psychotic symptoms: Static and dynamic association with transition to psychosis, non-remission and transdiagnostic symptomatology in clinical high-risk patients in an international intervention trial by Nelson, B, Yuen, H P, Amminger, G P, Berger, G, Chen, E Y H, de Haan, L, Hartmann, J A, Hickie, I B, Lavoie, S, Markulev, C, Mossaheb, N, Nieman, D H, Nordentoft, M, Polari, A, Riecher-Rössler, A, Schäfer, M R, Schlögelhofer, M, Smesny, S, Tedja, A, Thompson, A, Verma, S, Yung, A R, McGorry, P D

“…This study examined whether distress in relation to attenuated psychotic symptoms (DAPS) is associated with clinical outcomes in an ultra-high-risk (UHR) for…”
Get full text

Spatio-temporal selectivity of loss of colour and luminance contrast sensitivity with multiple sclerosis and optic neuritis by Flanagan, Patrick, Markulev, Connie

“…Colour and luminance‐contrast thresholds were measured in the presence of dynamic Random Luminance‐contrast Masking (RLM) in individuals who had had past…”
Get full text

0103 PHOSPHOLIPASE-A2 ACTIVITY PREDICTS SHORT-TERM OUTCOME IN FIRST EPISODE PSYCHOSIS by Yun, Y., Berger, G., Smesny, S., Law, M., Proffitt, T.-M., Wood, S., McConchie, M., Kerr, M., Markulev, C., Cotton, R., McGorry, P.

Get full text